NEW YORK (GenomeWeb) – Startups in Canada and France are combining their genomic analysis and machine learning technology in pursuit of faster, more accurate diagnoses of rare conditions.

Toronto-based Gene42, maker of software that supports precision medicine programs, is partnering with SeqOne, a French developer of a genome analysis platform, to augment gene sequences with phenotypic data from clinical encounters. This collaboration, the companies said today, will address the estimated 80 percent of rare diseases with genetic causes.